Yiqi Xugu HeJi restores cartilage metabolic homeostasis via AKT1-Thr473 activation in osteoarthritis
Phytomedicine · 2025
DOI: 10.1016/j.phymed.2025.157228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Zugui Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical College of Yunnan University of Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming …. Hauptthemen laut MEDLINE: Osteoarthritis, Proto-Oncogene Proteins c-akt, Drugs, Chinese Herbal, Cartilage, Articular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Yunnan Provincial Science and Technology Department, National Natural Science Foundation of China, Yunnan University.
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) is a degenerative joint disease marked by cartilage degradation, inflammation, and changes in subchondral bone structure. Despite its widespread use in treating OA, the mechanisms of traditional Chinese medicine (TCM) are not well understood. PURPOSE: This study aimed to explore the bioactive components and therapeutic mechanism of Yiqi Xugu HeJi (YQXGHJ), a classic TCM prescription, in alleviating OA progression. METHODS: A destabilization of the medial meniscus (DMM)-induced OA rat model was established to evaluate the protective effects of YQXGHJ. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) identified serum-absorbed compounds, while network pharmacology and molecular docking predicted potential targets. Cellular and molecular validation, including CCK-8, EdU, flow cytometry, qPCR, Western blotting, immunofluorescence, and Transwell assays, were performed in IL-1β-induced chondrocyte inflammation models. Key signaling pathways were verified using the AKT inhibitor MK2206. RESULTS: YQXGHJ significantly alleviated cartilage degeneration and subchondral bone sclerosis in DMM rats. In vitro, YQXGHJ-containing serum promoted chondrocyte proliferation, suppressed apoptosis, and restored the balance between anabolic (COL2A1, SOX9) and catabolic (MMP13, IL-6) markers. Network pharmacology and docking pinpointed AKT1 as a central target, with KEGG analysis emphasizing the PI3K-AKT pathway. Western blot and immunofluorescence confirmed that YQXGHJ activated PI3K/AKT signaling and enhanced phosphorylation at the AKT1-T473 site. Inhibition of AKT1 phosphorylation by MK2206 abolished these protective effects, confirming pathway specificity. CONCLUSION: YQXGHJ mitigates OA progression by reestablishing cartilage metabolic balance through the activation of the PI3K/AKT signaling pathway, specifically enhancing AKT1-T473 phosphorylation. This study provides a pharmacological and mechanistic foundation for the clinical use of YQXGHJ in treating OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Clinical College of Yunnan University of Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650000, China; Guangdong Cardiovascular Institute, Guangdong Provincia…
- Scientific Research Center, The Seventh Affliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- College of Basic Medicine, Yunnan University of Chinese Medicine, Yunnan Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Kunming 650000,…
- The Third Clinical College of Yunnan University of Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650000, China.
- The Third Clinical College of Yunnan University of Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650000, China. Electronic address: 254229226@qq.com.
- The Third Clinical College of Yunnan University of Chinese Medicine, The Third Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650000, China. Electronic address: dongweiky@sina.com.
Förderung
- Yunnan Provincial Science and Technology Department
- National Natural Science Foundation of China
- Yunnan University
Zitieren
APA
Wu, Z., Xu, H., Qiao, B., Zhu, Y., Yuan, R., Wu, Z., Li, S., Li, J., Xu, Y., Dong, W., & Guo, Y. (2025). Yiqi Xugu HeJi restores cartilage metabolic homeostasis via AKT1-Thr473 activation in osteoarthritis. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157228
Vancouver
Wu Z, Xu H, Qiao B, Zhu Y, Yuan R, Wu Z, et al. Yiqi Xugu HeJi restores cartilage metabolic homeostasis via AKT1-Thr473 activation in osteoarthritis. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157228
BibTeX
@article{Wu2025,
author = {Wu, Zugui and Xu, Huazhen and Qiao, Bo and Zhu, Yue and Yuan, Rong and Wu, Zhiwei and Li, Shixian and Li, Jiao and Xu, Yanfei and Dong, Wei and Guo, Ying},
title = {Yiqi Xugu HeJi restores cartilage metabolic homeostasis via AKT1-Thr473 activation in osteoarthritis},
journal = {Phytomedicine},
year = {2025},
doi = {10.1016/j.phymed.2025.157228}
}
EUVIMED